Technology ❯Biotechnology

Drug Development

GLP-1 Agonists Clinical Trials Innovative Therapies High-Throughput Screening Computational Methods NaV1.8 Inhibitors MorphoSys Immunotherapies Press Releases Neuroscience Antivenom Production Antivenom Research Biosimilars Natural Products Cancer Drugs

Researchers Transform Ancient Tomb Fungus Into Potent Antileukemia Compound

Identification of asperigimycins as potent antileukemia agents paves way for animal trials

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

Human-Derived Antibodies Drive Progress Toward Universal Snakebite Antivenom

UC Davis Develops LSD Analog JRT With Breakthrough Neuroplastic Benefits and Reduced Hallucinogenic Risks

AI-Designed Proteins Show Promise in Neutralizing Snake Venom Toxins

Xenon Pharmaceuticals to Showcase at BofA CNS Therapeutics Conference

Novartis Acquires MorphoSys for $2.9 Billion, Expanding Cancer Drug Portfolio

Vertex's Non-Opioid Painkiller Shows Promising Results in Mid-Stage Trial